Header Logo

Connection

Fawzia Bardag to Enzyme Inhibitors

This is a "connection" page, showing publications Fawzia Bardag has written about Enzyme Inhibitors.
Connection Strength

0.790
  1. Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease. Exp Mol Pathol. 2011 Feb; 90(1):123-30.
    View in: PubMed
    Score: 0.348
  2. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared. Life Sci. 2004 Jun 18; 75(5):585-97.
    View in: PubMed
    Score: 0.224
  3. The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats. Exp Mol Pathol. 2012 Aug; 93(1):99-110.
    View in: PubMed
    Score: 0.096
  4. CYP2E1 inhibition enhances mallory body formation. Exp Mol Pathol. 2005 Jun; 78(3):207-11.
    View in: PubMed
    Score: 0.059
  5. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies. Exp Mol Pathol. 2002 Oct; 73(2):75-83.
    View in: PubMed
    Score: 0.050
  6. The p105/50 NF-kappaB pathway is essential for Mallory body formation. Exp Mol Pathol. 2005 Jun; 78(3):198-206.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.